Literature DB >> 6424030

Serum beta 2-microglobulin binds to a T-cell differentiation antigen and increases its expression.

R F Kefford, F Calabi, I M Fearnley, O R Burrone, C Milstein.   

Abstract

The human T-cell leukaemia and differentiation antigen HTA 1 is defined by the monoclonal antibody NA1/34 (ref. 1) and also recognized by the monoclonal antibody OKT6. Like class I products of the human major histocompatibility complex, it has a glycosylated heavy (alpha) chain of approximately 45-50,000 molecular weight (MW) in non-covalent association with beta 2-microglobulin (beta 2m) (MW 11,900). A particular feature of HTA 1 is the presence in significant amounts of an additional beta 2m-like subunit, called beta t (refs 3, 4). Top facilitate biochemical studies we have prepared a high HTA 1 expressor variant (NH17) of the human thymoma line MOLT-4. The N-terminal amino acid sequence of the beta t purified from this cell line was shown to be indistinguishable from that of bovine beta 2m. Further, beta t was present when the cells were grown in medium containing fetal calf serum (FCS), but absent from cells grown with human serum (HuS). We show here that addition of human and bovine beta 2m to MOLT-4 and NH17 cells grown in serum-free medium produces a significant elevation of HTA 1 antigen expression, providing evidence for a regulatory or stabilizing function for the exchange of extracellular beta 2m with a cell-surface antigen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424030     DOI: 10.1038/308641a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  17 in total

1.  Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens.

Authors:  L H Martin; F Calabi; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens.

Authors:  C Due; M Simonsen; L Olsson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Structure and expression of the human thymocyte antigens CD1a, CD1b, and CD1c.

Authors:  L H Martin; F Calabi; F A Lefebvre; C A Bilsland; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Association between CAM 5.2 and anti-CD1a reactivity in lymph nodes and gastrointestinal tract epithelium.

Authors:  A S Jack; I Grigor; C J O'Brien; W McMeekin; F Lewis; A M McNicol
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

5.  Isolation and characterization of a cDNA and gene coding for a fourth CD1 molecule.

Authors:  S P Balk; P A Bleicher; C Terhorst
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  MHC class I and class I-like gene product expression by malignant T cells: relationships between CD1a, HLA-ABC and beta 2-microglobulin.

Authors:  R A Jones; C S Scott; F E Katz; J A Child
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

7.  A rapid solid-phase protein microsequencer.

Authors:  J E Walker; I M Fearnley; R A Blows
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

8.  Amino acid sequences in the alpha 1 domain and not glycosylation are important in HLA-A2/beta 2-microglobulin association and cell surface expression.

Authors:  J Santos-Aguado; P A Biro; U Fuhrmann; J L Strominger; J A Barbosa
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

9.  Sequence divergence of B2m alleles of wild Mus musculus and Mus spretus implies positive selection.

Authors:  E Hermel; P J Robinson; J X She; K F Lindahl
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

10.  A cell-based MHC stabilization assay for the detection of peptide binding to the canine classical class I molecule, DLA-88.

Authors:  Peter Ross; Jennifer C Holmes; Gregory S Gojanovich; Paul R Hess
Journal:  Vet Immunol Immunopathol       Date:  2012-09-21       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.